Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience.

Elbeddini, Ali; Hooda, Naushin; Gazarin, Mohamed; Webster, Penny; McMillan, Jackie

Elbeddini, Ali; Hooda, Naushin; Gazarin, Mohamed; Webster, Penny; McMillan, Jackie.

Afiliação

Elbeddini A; Clinical Pharmacy Department, Winchester District Memorial Hospital, Winchester, ON, Canada.
Hooda N; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
Gazarin M; Department of Research, Winchester District Memorial Hospital, Winchester, ON, Canada.
Webster P; Division of Ambulatory Care, Oncology Unit, Winchester District Memorial Hospital, Winchester, ON, Canada.
McMillan J; Division of Ambulatory Care, Oncology Unit, Winchester District Memorial Hospital, Winchester, ON, Canada.

Am J Case Rep ; 21: e924058, 2020 Jun 28.

Article em En | MEDLINE | ID: mdl-32594093

Assuntos

Disartria/induzido quimicamente; Irinotecano/efeitos adversos; Neoplasias Pancreáticas/tratamento farmacológico; Inibidores da Topoisomerase I/efeitos adversos; Idoso; Feminino; Humanos; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Disartria / Inibidores da Topoisomerase I / Irinotecano Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google